0 McAlinden Surgical Ltd 16650818 false 2025-08-14 2026-05-31 2026-05-31 The principal activity of the company is specialist medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 16650818 2025-08-14 2026-05-31 16650818 2026-05-31 16650818 bus:OrdinaryShareClass1 bus:CumulativeShares 2026-05-31 16650818 core:CurrentFinancialInstruments core:WithinOneYear 2026-05-31 16650818 core:MotorVehicles 2026-05-31 16650818 core:PlantMachinery 2026-05-31 16650818 bus:SmallEntities 2025-08-14 2026-05-31 16650818 bus:AuditExemptWithAccountantsReport 2025-08-14 2026-05-31 16650818 bus:FilletedAccounts 2025-08-14 2026-05-31 16650818 bus:SmallCompaniesRegimeForAccounts 2025-08-14 2026-05-31 16650818 bus:RegisteredOffice 2025-08-14 2026-05-31 16650818 bus:Director1 2025-08-14 2026-05-31 16650818 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-08-14 2026-05-31 16650818 bus:PrivateLimitedCompanyLtd 2025-08-14 2026-05-31 16650818 bus:Agent1 2025-08-14 2026-05-31 16650818 core:MotorVehicles 2025-08-14 2026-05-31 16650818 core:OfficeEquipment 2025-08-14 2026-05-31 16650818 core:PlantMachinery 2025-08-14 2026-05-31 16650818 countries:Wales 2025-08-14 2026-05-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 16650818

McAlinden Surgical Ltd

Unaudited Filleted Abridged Financial Statements

for the Period from 14 August 2025 to 31 May 2026

 

McAlinden Surgical Ltd

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 8

 

McAlinden Surgical Ltd

Company Information

Director

Colm McAlinden

Registered office

10 Yr Hafan
Swansea
West Glamorgan
SA1 8RD

Bankers

Tide
4th Floor
The Featherstone Building
66 City Road
London
EC1Y 2AL

Accountants

Kennedy & Co
Chartered Certified Accountants21 Kilmorey Street
Newry
Co Down
BT34 2DF

 

McAlinden Surgical Ltd

(Registration number: 16650818)
Abridged Balance Sheet as at 31 May 2026

Note

2026
£

Fixed assets

 

Tangible assets

4

38,866

Current assets

 

Cash at bank and in hand

 

519,625

Prepayments and accrued income

 

6,943

Creditors: Amounts falling due within one year

(141,966)

Net current assets

 

384,602

Total assets less current liabilities

 

423,468

Accruals and deferred income

 

(2,400)

Net assets

 

421,068

Capital and reserves

 

Called up share capital

5

125

Retained earnings

420,943

Shareholders' funds

 

421,068

 

McAlinden Surgical Ltd

(Registration number: 16650818)
Abridged Balance Sheet as at 31 May 2026

For the financial period ending 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

•

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

The financial statements were approved and authorised by the director on 30 September 2026
 

.........................................

Colm McAlinden
Director

 

McAlinden Surgical Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 14 August 2025 to 31 May 2026

1

General information

The company is a private company limited by share capital, incorporated in Wales.

The address of its registered office is:
10 Yr Hafan
Swansea
West Glamorgan
SA1 8RD

These financial statements were authorised for issue by the director on 30 September 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in sterling which is the functional currency of the company.

All members have consented to the abridgement of these financial statements.

 

McAlinden Surgical Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 14 August 2025 to 31 May 2026

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable net of trade discounts. The policies adopted for the recognition of turnover are as follows:


Rendering of services

When the outcome of a transaction can be estimated reliably, turnover from the provision of medical services is recognised by reference to the stage of completion at the balance sheet date. Stage of completion is measured by reference to the percentage of the medical journey that has been completed.

Where the outcome cannot be measured reliably, turnover is recognised only to the extent of the expenses recognised that are recoverable.

Interest Receivable
Interest Income is recognised using the effective interest method.

Tax

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset.

Tangible assets

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Asset class

Depreciation method and rate

Office Equipment

15% Reducing Balance Basis

Motor Vehicle

25% Reducing Balance Basis

 

McAlinden Surgical Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 14 August 2025 to 31 May 2026

Provisions

Provisions are recognised when the company has an obligation at the balance sheet date as a result of a past event, it is probable that an outflow of economic benefits will be required in settlement and the amount can be reliably estimated.

Impairment

Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset’s cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 0.

 

McAlinden Surgical Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 14 August 2025 to 31 May 2026

4

Tangible assets

Office Equipment
£

Motor Vehicle
£

Total
£

Cost or valuation

Additions

1,018

45,494

46,512

At 31 May 2026

1,018

45,494

46,512

Depreciation

Charge for the period

64

7,582

7,646

At 31 May 2026

64

7,582

7,646

Carrying amount

At 31 May 2026

954

37,912

38,866

 

McAlinden Surgical Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 14 August 2025 to 31 May 2026

5

Share capital

Allotted, called up and fully paid shares

2026

No.

£

Ordinary Shares of £1 each

125

125